Longboard shareholders approve officer exculpation amendment; director Jane Tiller resigns

Longboard Pharmaceuticals, Inc.

Shareholders approved Officer Exculpation Amendment limiting officer liability under Delaware law (25.2M for, 4.7M against).
Director Jane Tiller resigned effective May 23, 2024, due to change in primary employment; no disagreement with company.
Paul J. Sekhri and Phillip M. Schneider elected as Class III directors until 2027 annual meeting.
KPMG LLP ratified as independent auditor for fiscal year ending Dec 31, 2024 (30.7M for).

item 3.03 item 5.07 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jane Tiller

Director

Longboard Pharmaceuticals, Inc.

Effective: 2024-05-23
Filed: May 24, 2024, 7:59 PM ET

On May 23, 2024, Jane Tiller, MBChB, FRCPsych, a member of Longboard’s Board of Directors (the “Board”), notified the Board of her resignation from the Board and its committees effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jane Tiller resigned as Director at Longboard Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 23, 2024, Jane Tiller, MBChB, FRCPsych, a member of Longboard’s Board of Directors (the “Board”), notified the Board of her resignation from the Board and its committees effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-064559

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.